Why MNOV? MediciNova, Inc. Analysis, Price & AI Insights | Whystock
MNOV
$1.40+0.01 (+0.72%)
Market ClosedLast close May 1
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.